earnings
confidence high
sentiment positive
materiality 0.70
KORU Medical Q2 revenue up 21% to record $10.2M; raises FY 2025 revenue guidance
KORU Medical Systems, Inc.
2025-Q2 EPS reported
$0.03
revenue$19,829,875
- Q2 2025 net revenue of $10.2 million, +21% YoY; Core revenue $9.3M (+19%), PST $0.9M (+42%).
- Adjusted EBITDA positive $0.3M vs ($0.4M) in prior year; net loss narrowed to $0.2M from $1.3M.
- Raises FY 2025 revenue guidance to $39.5-$40.5M (prev. $38.5-$39.5M); gross margin guidance 61%-63% reaffirmed.
- Cash balance $8.1M at Q2-end; reiterated positive operating cash flow for FY 2025.
- Adam Kalbermatten named Chief Commercial Officer; FDA 510(k) submitted for a rare disease biologic drug.
item 2.02item 9.01